Evaluation of cell-free DNA approaches for multi-cancer early detection

被引：106

作者：

Jamshidi, Arash ^{[1
]}

Liu, Minetta C. ^{[2
,18
]}

Klein, Eric A. ^{[3
]}

Venin, Oliver ^{[1
]}

Hubbell, Earl ^{[1
]}

Beausang, John F. ^{[1
]}

Gross, Samuel ^{[1
]}

Melton, Collin ^{[1
]}

Fields, Alexander P. ^{[1
]}

Liu, Qinwen ^{[1
]}

Zhang, Nan ^{[1
]}

Fung, Eric T. ^{[1
]}

Kurtzman, Kathryn N. ^{[1
]}

Amini, Hamed ^{[1
]}

Betts, Craig ^{[1
,19
]}

Civello, Daniel ^{[1
,20
]}

Freese, Peter ^{[1
,21
]}

Calef, Robert ^{[1
]}

Davydov, Konstantin ^{[1
,22
]}

Fayzullina, Saniya ^{[1
]}

Hou, Chenlu ^{[1
]}

Jiang, Roger ^{[1
]}

Jung, Byoungsok ^{[1
]}

Tang, Susan ^{[1
,23
]}

Demas, Vasiliki ^{[24
]}

Newman, Joshua ^{[1
]}

Sakarya, Onur ^{[1
]}

Scott, Eric ^{[1
]}

Shenoy, Archana ^{[1
]}

Shojaee, Seyedmehdi ^{[1
]}

Steffen, Kristan K. ^{[1
]}

Nicula, Virgil ^{[1
]}

Chien, Tom C. ^{[1
]}

Bagaria, Siddhartha ^{[1
]}

Hunkapiller, Nathan ^{[1
]}

Desai, Mohini ^{[1
]}

Dong, Zhao ^{[1
]}

Richards, Donald A. ^{[4
]}

Yeatman, Timothy J. ^{[5
,6
]}

Cohn, Allen L. ^{[7
]}

Thiel, David D. ^{[8
]}

Berry, Donald A. ^{[9
]}

Tummala, Mohan K. ^{[10
]}

MCIntyre, Kristi ^{[11
]}

Sekeres, Mikkael A. ^{[12
]}

Bryce, Alan ^{[13
]}

Aravanis, Alexander M. ^{[14
]}

V. Seiden, Michael ^{[1
,15
]}

Swanton, Charles ^{[16
,17
]}

机构：

[1] GRAIL LLC, Menlo Pk, CA 94025 USA

[2] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA

[3] Cleveland Clin, Cleveland, OH 44103 USA

[4] Texas Oncol, Tyler, TX 75702 USA

[5] Gibbs Canc Ctr & Res Inst, Spartanburg, SC 29303 USA

[6] Univ Utah, Dept Surg, Salt Lake City, UT 84112 USA

[7] Rocky Mt Canc Ctr, Denver, CO 80218 USA

[8] Mayo Clin Florida, Dept Urol, Jacksonville, FL 32224 USA

[9] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[10] Mercy Clin Canc Ctr, Springfield, MO 65804 USA

[11] TOPA Dallas Presbyterian, Dallas, TX 75231 USA

[12] Univ Miami, Sylvester Canc Ctr, Miami, FL 33136 USA

[13] Mayo Clin, Phoenix, AZ 85054 USA

[14] Illumina Inc, San Diego, CA 92122 USA

[15] US Oncol Res, The Woodlands, TX 77380 USA

[16] Francis Crick Inst, London NW1 1AT, England

[17] UCL Canc Inst, CRUK Lung Canc Ctr Excellence, London WC1E 6DD, England

[18] Natera Inc, Austin, TX 78753 USA

[19] Cellanome Inc, Palo Alto, CA 94303 USA

[20] Loyal Cellular Longev Inc, Menlo Pk, CA 94025 USA

[21] Meta, Menlo Pk, CA 94025 USA

[22] Aurora Innovat Inc, Mountain View, CA 94043 USA

[23] Strateos Inc, Menlo Pk, CA 94025 USA

[24] Tesseract Hlth, Guilford, CT 06437 USA

来源：

CANCER CELL | 2022年 / 40卷 / 12期

关键词：

CIRCULATING TUMOR DNA; LIQUID BIOPSY; PLASMA; VALIDATION; SURVIVAL; FRACTION;

D O I：

10.1016/j.ccell.2022.10.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In the Circulating Cell-free Genome Atlas (NCT02889978) substudy 1, we evaluate several approaches for a circulating cell-free DNA (cfDNA)-based multi-cancer early detection (MCED) test by defining clinical limit of detection (LOD) based on circulating tumor allele fraction (cTAF), enabling performance compar-isons. Among 10 machine-learning classifiers trained on the same samples and independently validated, when evaluated at 98% specificity, those using whole-genome (WG) methylation, single nucleotide var-iants with paired white blood cell background removal, and combined scores from classifiers evaluated in this study show the highest cancer signal detection sensitivities. Compared with clinical stage and tumor type, cTAF is a more significant predictor of classifier performance and may more closely reflect tumor biology. Clinical LODs mirror relative sensitivities for all approaches. The WG methylation feature best predicts cancer signal origin. WG methylation is the most promising technology for MCED and informs development of a targeted methylation MCED test.

引用

页码：1537 / +

页数：26

共 50 条

[1] Evaluation of cell-free DNA approaches for multi-cancer early detection
Liu, M. C.
Jamshidi, A.
Klein, E. A.
Venn, O.
Hubbell, E.
Beausang, J. F.
Zhang, N.
Kurtzman, K. N.
Hou, C.
Richards, D. A.
Yeatman, T. J.
Cohn, A. L.
Thiel, D. D.
Tummala, M. K.
McIntyre, K.
Sekeres, M. A.
Bryce, A. H.
Seiden, M. V.
Swanton, C.
ANNALS OF ONCOLOGY, 2021, 32 : S921 - S921
[2] Circulating cell-free DNA-based multi-cancer early detection
Zhang, Kai
Fu, Ruiqing
Liu, Rui
Su, Zhixi
TRENDS IN CANCER, 2024, 10 (02): : 161 - 174
[3] Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization
Nguyen, Van Thien Chi
Nguyen, Trong Hieu
Doan, Nhu Nhat Tan
Pham, Thi Mong Quynh
Nguyen, Giang Thi Huong
Nguyen, Thanh Dat
Tran, Thuy Thi Thu
Vo, Duy Long
Phan, Thanh Hai
Jasmine, Thanh Xuan
Nguyen, Van Chu
Nguyen, Huu Thinh
Nguyen, Trieu Vu
Nguyen, Thi Hue Hanh
Huynh, Le Anh Khoa
Tran, Trung Hieu
Dang, Quang Thong
Doan, Thuy Nguyen
Tran, Anh Minh
Nguyen, Viet Hai
Nguyen, Vu Tuan Anh
Ho, Le Minh Quoc
Tran, Quang Dat
Pham, Thi Thu Thuy
Ho, Tan Dat
Nguyen, Bao Toan
Nguyen, Thanh Nhan Vo
Nguyen, Thanh Dang
Phu, Dung Thai Bieu
Phan, Boi Hoan Huu
Vo, Thi Loan
Nai, Thi Huong Thoang
Tran, Thuy Trang
Truong, My Hoang
Tran, Ngan Chau
Le, Trung Kien
Tran, Thanh Huong Thi
Duong, Minh Long
Bach, Hoai Phuong Thi
Kim, Van Vu
Pham, The Anh
Tran, Duc Huy
Le, Trinh Ngoc An
Pham, Truong Vinh Ngoc
Le, Minh Triet
Vo, Dac Ho
Tran, Thi Minh Thu
Nguyen, Minh Nguyen
Van, Thi Tuong Vi
Nguyen, Anh Nhu
ELIFE, 2023, 12
[4] An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection
Shao, Yang
Bao, Hua
Wang, Zheng
Ma, Xiaoji
Guo, Wei
Zhang, Xiangyu
Wang, Xinyu
Chen, Yikuan
Mo, Shaobo
Liang, Naixin
Ma, Qianli
Li, Yaqi
Zhang, Long
Tan, Fengwei
Xue, Qi
Liu, Fangqi
Cai, Sanjun
Gao, Shugeng
Peng, Junjie
Zhou, Jian
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[5] Plasma cell-free DNA (cfDNA) assays for early multi-cancer detection: The circulating cell-free genome atlas (CCGA) study
Liu, M. C.
Klein, E.
Hubbell, E.
Maddala, T.
Aravanis, A. M.
Beausang, J. F.
Filippova, D.
Gross, S.
Jamshidi, A.
Kurtzman, K.
Shen, L.
Zhang, N.
Venn, O.
Yecies, J.
Patel, S.
Smith, D. A.
Yeatman, T.
Seiden, M.
Hartman, A-R.
Oxnard, G.
ANNALS OF ONCOLOGY, 2018, 29 : 14 - 14
[6] An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection
Bao, Hua
Wang, Zheng
Ma, Xiaoji
Guo, Wei
Zhang, Xiangyu
Tang, Wanxiangfu
Chen, Xin
Wang, Xinyu
Chen, Yikuan
Mo, Shaobo
Liang, Naixin
Ma, Qianli
Wu, Shuyu
Xu, Xiuxiu
Chang, Shuang
Wei, Yulin
Zhang, Xian
Bao, Hairong
Liu, Rui
Yang, Shanshan
Jiang, Ya
Wu, Xue
Li, Yaqi
Zhang, Long
Tan, Fengwei
Xue, Qi
Liu, Fangqi
Cai, Sanjun
Gao, Shugeng
Peng, Junjie
Zhou, Jian
Shao, Yang
MOLECULAR CANCER, 2022, 21 (01)
[7] Cell-free DNA approaches for cancer early detection and interception
Medina, Jamie E.
Dracopoli, Nicholas C.
Bach, Peter B.
Lau, Anna
Scharpf, Robert B.
Meijer, Gerrit A.
Andersen, Claus Lindbjerg
Velculescu, Victor E.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
[8] Multimodal analysis of plasma cell-free DNA methylome for sensitive multi-cancer detection
Li, Yulong
Bie, Fenglong
Tan, Fengwei
Han, Tiancheng
Yang, Shunli
Lv, Fang
Nie, Peiyao
Zhang, Qi
Hong, Yuanyuan
Wang, Zhijie
He, Ji
Chen, Weizhi
Zhao, Liang
Gao, Shugeng
CANCER RESEARCH, 2022, 82 (12)
[9] Assessment of plasma cell-free DNA fragmentation for multi-cancer early detection: An independent clinical validation study
Guo, Wei
Hu, Yunlong
Wang, Wei
Zhou, Yanqing
Yang, Zuoquan
An, Heng
Yang, Qing
Lv, Yanhua
Lu, Chao
Zhang, Xiaoni
Xu, Mingyan
Xia, Yong
Ji, Ling
Chen, Shifu
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[10] Prediction of cancer and tissue of origin in individuals with suspicion of cancer using a cell-free DNA multi-cancer early detection test
Thiel, David D.
Chen, Xiaoji
Kurtzman, Kathryn N.
Yecies, Jessica
Wu, Tony
Zhang, Quan
Liu, Hai
Zhang, Nan
Fung, Eric T.
Seiden, Michael, V
Liu, Minetta C.
Oxnard, Geoffrey R.
Hubbell, Earl
Aravanis, Alexander M.
Hartman, Anne-Renee
Klein, Eric A.
CANCER RESEARCH, 2020, 80 (16)

← 1 2 3 4 5 →